MPM
WST icon

MBB Public Markets’s West Pharmaceutical WST Stock Holding History

MBB Public Markets’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,129
Closed -$247K – 490
2025
Q2 		$247K Sell
1,129
-262
-19% -$56K 0.02% 382
2025
Q1 		$311K Buy
+1,391
New +$383K 0.03% 334
2024
Q4 		– Sell
-900
Closed -$270K – 551
2024
Q3 		$270K Sell
900
-4,330
-83% -$1.33M 0.02% 514
2024
Q2 		$1.72M Buy
+5,230
New +$1.85M 0.03% 385
2022
Q1 		– Sell
-651
Closed -$305K – 470
2021
Q4 		$305K Buy
+651
New +$280K 0.01% 351

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

MBB Public Markets's WST Position: Q3 2025 in Review

MBB Public Markets sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 1,129 shares — an estimated $247K sold.

MBB Public Markets first reported a position in WST in Q4 2021 and held it in 5 quarters. The position peaked at $1.72M in Q2 2024. 756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • MBB Public Markets reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • MBB Public Markets sold 1,129 West Pharmaceutical shares in Q3 2025, an estimated $247K.
  • MBB Public Markets first reported a position in West Pharmaceutical in Q4 2021 and held it in 5 quarters.
  • MBB Public Markets's West Pharmaceutical position peaked at $1.72M in Q2 2024.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on MBB Public Markets's 13F filing for Q3 2025, filed 14 Nov 2025.